Imidazolines compounds elicit diverse effects on cell growth and death. At least, three subtypes of imidazoline receptors I 1 Rs have been described: I 1 R, I 2 R and I 3 R. [1] [2] [3] Some imidazoline ligands are potent inhibitors of vascular smooth muscle cell proliferation through the activation of I 2 R. 2 Other imidazoline compounds inhibited the growth of clonal pancreatic b-cells by an unknown mechanism. 4 In contrast, independent of imidazoline receptors, some imidazoline compounds protect cerebellar granule cells against glutamate-induced neurotoxicity. 5 At present, no effect dependent on I 1 R stimulation on survival or cell death is described. However, a recent study has demonstrated a neuroprotective effect of several imidazoline, having affinity for I 1 R, on cytotoxicity induced by naphthazarin in astrocystes. 6 But, this neuroprotection does not depend on I 1 R stimulation. Our laboratory is interested in I 1 imidazoline receptor. I 1 Rs are involved in the central regulation of blood pressure and cardiovascular function. 7 Some cell lines, such as PC12 cells, express the I 1 R localized on plasma membranes. 1 In these cells, several transduction pathways associated with the receptors have been described: imidazolines, such as benazoline, increase the diacylglycerol level in the cells through the activation of a phosphatidylcholine-specific phospholipase C (PC-PLC) and decrease concentration-dependently the forskolin-stimulated cAMP level in insensitive-pertussis toxin manner. 1 These two transduction pathways are largely involved in the signalling of cell growth, cell transformation and cell death. The present work addressed the issue of the implication of I 1 R in death or growth of PC12 cells.
To examine a potential role for I 1 R in protection against apoptosis, we used cell death model induced by serum deprivation. When PC12 cells are deprived of serum, they undergo apoptosis or programmed cell death. 8 The death was assessed by counting trypan blue excluding cells with a hemacytometer. The apoptotic population was quantitatively evaluated by Hoechst staining nuclei. Under serum-deprivation condition, we observed a significant decrease of viable cells time-dependently as compared with control time 0 (Figure 1a, left panel) . From 8 h, the cell death was yet 40% and reached 65% at 48 h. This cell death was associated with an enhancement of chromatin condensation (972.8%) as compared with serum-containing condition (0.570%) (Figure 1a , middle panel). Apoptosis process induced by serum deprivation is known to be mediated by the mitochondrial pathway in which caspases 3 and 9 were activated. 8 So,
an increase of caspase-3-like activity was considered as a second index of apoptosis. We therefore measured the activity of this enzyme after serum deprivation and compared to serum-containing condition. From 3 h, caspase-3-like activity increased significantly in serum-deprivation condition to reach a plateau at 6 h and remained until 24 h in comparison with serum-containing condition ( Figure 1a , right panel). Then, these results showed that PC12 cells died by apoptosis under serum-deprivation condition.
To examine I 1 R implication on PC12 cell death, we used benazoline, an agonist of two transduction pathways, which has a high affinity and is selective for I 1 R. 1 Under normal growing conditions, that is in the presence of serum, benazoline did not have proapoptotic effect on PC12 cells (data not shown). Under apoptosis condition, benazoline (10 À6 M) was added at the onset of serum deprivation and led incubate until 48 h. Benazoline enhanced significantly cell death induced by serum deprivation at 8 and 24 h ( Figure 1b , upper panel). After 24 h, this effect disappeared and returned to the level of serum-deprivation condition. The increase was 18 and 25% at 8 and 24 h, respectively, as compared with control in the absence of serum for the same time. This enhancement of cell death by benazoline was associated with an increase of chromatin condensation (2672.6%) at 24 h ( Figure 1b , lower panel). Since caspase-3 was activated in this apoptotic process, we next measured its activity. The cells were incubated 6 h because we had the maximal effect of serum deprivation ( Figure 1a ). After 6-h serum-deprivation in the presence of benazoline, caspase-3 like activity was significantly enhanced concentration-dependently in comparison with serum-free control with an EC 50 of 5.7572.99 Â 10 À11 M and a maximal of 103 7 19% (Figure 1c , upper panel). These results proved that benazoline not only enhanced PC12 cells apoptosis associated with caspase-3 activation, but also accelerated the process in the first 24 h.
In order to prove that the effects of benazoline were due to I 1 R stimulation, different experiments were performed in the presence of efaroxan, which is an I 1 R reference and selective antagonist. 9 Under normal growing conditions, efaroxan (10 À5 M) had no pro-apoptotic effect on PC12 cells (data not shown). This result corroborates previous data obtained with efaroxan. 4 Under serum-free conditions, efaroxan had no effect by itself but blocked both effects of benazoline: the enhancement of cell death and the increase of caspase-3 like activity irrespective of the benazoline concentration www.nature.com/cdd ( Figure 1c) . As efaroxan, which was shown to antagonize the PC-PLC pathway associated with I 1 R, blocked benazoline effects, we hypothesized that the apoptotic pathway associated with I 1 R may involve PC-PLC. 9 To check this hypothesis, we used D609 that is a selective inhibitor of PC-PLC. 9 In apoptotic conditions, D609 had no effect by itself as compared with serum-deprivation condition (Figure 1d ). This inhibitor prevented completely the increase of caspase-3 like (Figure 1d ). Taken together, these results showed that activation of I 1 R facilitates apoptosis under serum-deprivation condition and that this effect involves the PC-PLC pathway. There are two major signalling pathways of apoptosis: (i) the mitochondrial pathway activated by serum deprivation; (ii) the death receptor pathway activated by cytokines such as tumor necrosis factor a (TNFa). These pathways converge to caspase-3 that then induces downstream events involved in a common apoptotic process. It has previously been shown that PC12 cells treated with TNFa underwent apoptosis. 10 In the present study, TNFa (50 ng/ml) increased significantly the caspase-3-like activity in comparison with control conditions from the 24th h onwards (Figure 1e ). This increase of caspase-3-like activity induced by TNFa was prevented by benazoline (10 À6 M), which was added at the onset of incubation (Figure 1e) . In order to prove the I 1 R implication in the protective effect of benazoline, we used the selective antagonist efaroxan. It had no effect by itself but blocked the decrease of caspase-3-like activity induced by benazoline (Figure 1e ). We confirmed the protective effect of benazoline on cell viability by counting trypan blue excluding cells. In the presence of TNFa, we observed a significant time-dependent decrease of the number of viable PC12 cells. When adding TNFa to the serum, it varied from 101.273.09 to 83.4872.37% (17% of decrease, Po0.01, n ¼ 3 in duplicate) at 24 h and from 13576.8 to 107.673.1% (20% of decrease, Po0.01, n ¼ 3 in duplicate) at 48 h. This decrease of the number of viable cells was prevented by benazoline (10 À6 M); a complete prevention was even observed at 48 h. These results indicated that benazoline was able to protect PC12 cells against TNFa cell death.
Finally, benazoline had two opposite effects mediated by I 1 R stimulation: induced a facilitation of serum-deprivationinduced apoptosis and a protective effect against cell death induced by TNFa. Similar effects were already described in transformed keratinocytes cell line. 11 In fact, interleukin-1 protected these cells from Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL) and CD95-induced apoptosis. In contrast, it enhanced keratinocyte apoptosis induced by ultraviolet radiation. 11 Under serum-deprivation conditions, BH 4 (tetrahydrobiopterin) had an effect similar to that of benazoline in PC12 cells. In fact, this compound also enhanced the rate of death in PC12 cells but only in apoptotic conditions associated with serum deprivation. The enhancement of cell death was completely abolished by a caspase inhibitor. BH 4 was unable to induce apoptosis in the presence of growth factors. 12 The effects of benazoline on apoptosis induced by TNFa were similar to the protective effects of some imidazoline-like compounds against cytotoxicity induced by naphthazarin in astrocytes. 6 In summary, we have shown for the first time that I 1 R might be involved in some apoptotic processes. The I 1 effects of imidazoline drugs on apoptotic processes clearly depend on the cell death model. 
